Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Mar. Drugs 2014, 12(6), 3323-3351; doi:10.3390/md12063323
Article

Metabolomic Profiling and Genomic Study of a Marine Sponge-Associated Streptomyces sp.

1,†
, 2,†
, 2,* , 1
, 2
, 2,3,4,5
, 2,3
, 2,3
 and 1,*
Received: 25 March 2014; in revised form: 7 May 2014 / Accepted: 21 May 2014 / Published: 2 June 2014
(This article belongs to the Special Issue Metabolomics - Applications in Marine Natural Products Chemistry)
View Full-Text   |   Download PDF [831 KB, uploaded 2 June 2014]
Abstract: Metabolomics and genomics are two complementary platforms for analyzing an organism as they provide information on the phenotype and genotype, respectively. These two techniques were applied in the dereplication and identification of bioactive compounds from a Streptomyces sp. (SM8) isolated from the sponge Haliclona simulans from Irish waters. Streptomyces strain SM8 extracts showed antibacterial and antifungal activity. NMR analysis of the active fractions proved that hydroxylated saturated fatty acids were the major components present in the antibacterial fractions. Antimycin compounds were initially putatively identified in the antifungal fractions using LC-Orbitrap. Their presence was later confirmed by comparison to a standard. Genomic analysis of Streptomyces sp. SM8 revealed the presence of multiple secondary metabolism gene clusters, including a gene cluster for the biosynthesis of the antifungal antimycin family of compounds. The antimycin gene cluster of Streptomyces sp. SM8 was inactivated by disruption of the antimycin biosynthesis gene antC. Extracts from this mutant strain showed loss of antimycin production and significantly less antifungal activity than the wild-type strain. Three butenolides, 4,10-dihydroxy-10-methyl-dodec-2-en-1,4-olide (1), 4,11-dihydroxy-10-methyl-dodec-2-en-1,4-olide (2), and 4-hydroxy-10-methyl-11-oxo-dodec-2-en-1,4-olide (3) that had previously been reported from marine Streptomyces species were also isolated from SM8. Comparison of the extracts of Streptomyces strain SM8 and its host sponge, H. simulans, using LC-Orbitrap revealed the presence of metabolites common to both extracts, providing direct evidence linking sponge metabolites to a specific microbial symbiont.
Keywords: Streptomyces; Haliclona simulans; metabolomics; antimycin; antifungal; butenolide Streptomyces; Haliclona simulans; metabolomics; antimycin; antifungal; butenolide
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Viegelmann, C.; Margassery, L.M.; Kennedy, J.; Zhang, T.; O'Brien, C.; O'Gara, F.; Morrissey, J.P.; Dobson, A.D.W.; Edrada-Ebel, R. Metabolomic Profiling and Genomic Study of a Marine Sponge-Associated Streptomyces sp.. Mar. Drugs 2014, 12, 3323-3351.

AMA Style

Viegelmann C, Margassery LM, Kennedy J, Zhang T, O'Brien C, O'Gara F, Morrissey JP, Dobson ADW, Edrada-Ebel R. Metabolomic Profiling and Genomic Study of a Marine Sponge-Associated Streptomyces sp.. Marine Drugs. 2014; 12(6):3323-3351.

Chicago/Turabian Style

Viegelmann, Christina; Margassery, Lekha M.; Kennedy, Jonathan; Zhang, Tong; O'Brien, Ciarán; O'Gara, Fergal; Morrissey, John P.; Dobson, Alan D.W.; Edrada-Ebel, RuAngelie. 2014. "Metabolomic Profiling and Genomic Study of a Marine Sponge-Associated Streptomyces sp.." Mar. Drugs 12, no. 6: 3323-3351.



Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert